Clinical Performance Evaluation of an Artificial Intelligence-Powered Amyloid Brain PET Quantification Method.
Seung Kwan KangMina HeoJi Yeon ChungDaewoon KimSeong A ShinHongyoon ChoiAri ChungJung-Min HaHoowon KimJae Sung LeePublished in: Nuclear medicine and molecular imaging (2024)
BTXBrain-Amyloid outperformed SPM in clinical performance evaluation, also demonstrating superior SN and improved detection of deep brain differences. These results suggest the potential of BTXBrain-Amyloid as a valuable tool for clinical amyloid PET image evaluation.